{
  "DOI": "10.1186/s40246-021-00320-9",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-021-00320-9",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eBackground\u003c/jats:title\u003e\n                \u003cjats:p\u003eNon-small cell lung carcinoma (NSCLC) is one of the most common human cancers, comprising approximately 80–85% of all lung carcinomas. An estimated incidence of NSCLC is approximately 2 million new cases per year worldwide.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eResults\u003c/jats:title\u003e\n                \u003cjats:p\u003eIn recent decade, the treatment of NSCLC has made breakthrough progress owing to a large number of targeted therapies which were approved for clinical use. Epidemiology, genetic susceptibility, and molecular profiles in patients are likely to play an important factor in response rates and survival benefits to these targeted treatments and thus warrant further investigation on ethnic differences in NSCLC. In this study, a total number of 1500 Chinese patient samples,1000 formalin fixed paraffin-embedded (FFPE) and 500 blood samples, from patients with NSCLC were analyzed by targeted sequencing to explore mutational landscape in ethnic groups associated with China.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eConclusions\u003c/jats:title\u003e\n                \u003cjats:p\u003eOverall, the data presented here provide a comprehensive analysis of NSCLC mutational landscape in Chinese patients and findings are discussed in the context of similar studies on different ethnic groups.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e",
  "alternative-id": [
    "320"
  ],
  "article-number": "21",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "18 December 2020"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "10 March 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "12 April 2021"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Ethics approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The study was conducted in accordance with the Helsinki Declaration and was approved by the institute’s Ethics Committee. All the patients enrolled had been informed about the content and purposes of this study and signed the consents."
    },
    {
      "group": {
        "label": "Consent for publication",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "Not applicable"
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 4,
      "value": "The authors declare that they have no competing interests."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Zhou",
      "given": "Ya-jun",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Zheng",
      "given": "Wei",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Zeng",
      "given": "Qing-hua",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ye",
      "given": "Yang",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Wang",
      "given": "Ce",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Fang",
      "given": "Cheng",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Liu",
      "given": "Chao-jun",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Niu",
      "given": "Li",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Wu",
      "given": "Li-ming",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2021,
        4,
        12
      ]
    ],
    "date-time": "2021-04-12T17:03:00Z",
    "timestamp": 1618246980000
  },
  "deposited": {
    "date-parts": [
      [
        2021,
        4,
        12
      ]
    ],
    "date-time": "2021-04-12T17:30:05Z",
    "timestamp": 1618248605000
  },
  "funder": [
    {
      "award": [
        "20181BBG78023"
      ],
      "name": "the Science and Technology Plan Fund Project of Science and Technology Department of Jiangxi Province"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        3,
        8
      ]
    ],
    "date-time": "2024-03-08T05:23:38Z",
    "timestamp": 1709875418358
  },
  "is-referenced-by-count": 7,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2021,
        4,
        12
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2021,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://creativecommons.org/licenses/by/4.0/",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            4,
            12
          ]
        ],
        "date-time": "2021-04-12T00:00:00Z",
        "timestamp": 1618185600000
      }
    },
    {
      "URL": "http://creativecommons.org/licenses/by/4.0/",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            4,
            12
          ]
        ],
        "date-time": "2021-04-12T00:00:00Z",
        "timestamp": 1618185600000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-021-00320-9.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1186/s40246-021-00320-9/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-021-00320-9.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2021,
        4,
        12
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2021,
        4,
        12
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2021,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1016/j.arcmed.2020.08.004",
      "doi-asserted-by": "crossref",
      "key": "320_CR1",
      "unstructured": "Suster DI, Mino-Kenudson M. Molecular pathology of primary non-small cell lung cancer. Arch Med Res. 2020."
    },
    {
      "DOI": "10.1097/JTO.0000000000000033",
      "author": "Y Shi",
      "doi-asserted-by": "publisher",
      "first-page": "154",
      "issue": "2",
      "journal-title": "J Thorac Oncol",
      "key": "320_CR2",
      "unstructured": "Shi Y, Au JS, Thongprasert S, Srinivasan S, Tsai CM, Khoa MT, et al. A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER). J Thorac Oncol. 2014;9(2):154–62. https://doi.org/10.1097/JTO.0000000000000033.",
      "volume": "9",
      "year": "2014"
    },
    {
      "DOI": "10.21037/jtd.2019.08.29",
      "author": "J Lee",
      "doi-asserted-by": "publisher",
      "first-page": "3796",
      "issue": "7",
      "journal-title": "J Thorac Dis",
      "key": "320_CR3",
      "unstructured": "Lee J, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ. Are there any ethnic differences in the efficacy and safety of immune checkpoint inhibitors for treatment of lung cancer? J Thorac Dis. 2020;12(7):3796–803. https://doi.org/10.21037/jtd.2019.08.29.",
      "volume": "12",
      "year": "2020"
    },
    {
      "DOI": "10.21037/jtd.2018.05.106",
      "author": "L Peng",
      "doi-asserted-by": "publisher",
      "first-page": "S1482",
      "issue": "Suppl 13",
      "journal-title": "J Thorac Dis",
      "key": "320_CR4",
      "unstructured": "Peng L, Wu YL. Immunotherapy in the Asiatic population: any differences from Caucasian population? J Thorac Dis. 2018;10(Suppl 13):S1482–S93. https://doi.org/10.21037/jtd.2018.05.106.",
      "volume": "10",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.annonc.2020.07.014",
      "author": "F Mosele",
      "doi-asserted-by": "publisher",
      "first-page": "1491",
      "issue": "11",
      "journal-title": "Ann Oncol",
      "key": "320_CR5",
      "unstructured": "Mosele F, Remon J, Mateo J, Westphalen CB, Barlesi F, Lolkema MP, Normanno N, Scarpa A, Robson M, Meric-Bernstam F, Wagle N, Stenzinger A, Bonastre J, Bayle A, Michiels S, Bièche I, Rouleau E, Jezdic S, Douillard JY, Reis-Filho JS, Dienstmann R, André F. Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group. Ann Oncol. 2020;31(11):1491–505. https://doi.org/10.1016/j.annonc.2020.07.014.",
      "volume": "31",
      "year": "2020"
    },
    {
      "DOI": "10.1056/NEJMoa1501824",
      "author": "EB Garon",
      "doi-asserted-by": "publisher",
      "first-page": "2018",
      "issue": "21",
      "journal-title": "N Engl J Med",
      "key": "320_CR6",
      "unstructured": "Garon EB, Rizvi NA, Hui R, Leighl N, Balmanoukian AS, Eder JP, Patnaik A, Aggarwal C, Gubens M, Horn L, Carcereny E, Ahn MJ, Felip E, Lee JS, Hellmann MD, Hamid O, Goldman JW, Soria JC, Dolled-Filhart M, Rutledge RZ, Zhang J, Lunceford JK, Rangwala R, Lubiniecki GM, Roach C, Emancipator K, Gandhi L. Pembrolizumab for the treatment of non-small-cell lung cancer. N Engl J Med. 2015;372(21):2018–28. https://doi.org/10.1056/NEJMoa1501824.",
      "volume": "372",
      "year": "2015"
    },
    {
      "DOI": "10.1126/science.aaa1348",
      "author": "NA Rizvi",
      "doi-asserted-by": "publisher",
      "first-page": "124",
      "issue": "6230",
      "journal-title": "Science.",
      "key": "320_CR7",
      "unstructured": "Rizvi NA, Hellmann MD, Snyder A, Kvistborg P, Makarov V, Havel JJ, Lee W, Yuan J, Wong P, Ho TS, Miller ML, Rekhtman N, Moreira AL, Ibrahim F, Bruggeman C, Gasmi B, Zappasodi R, Maeda Y, Sander C, Garon EB, Merghoub T, Wolchok JD, Schumacher TN, Chan TA. Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science. 2015;348(6230):124–8. https://doi.org/10.1126/science.aaa1348.",
      "volume": "348",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.cell.2012.08.024",
      "author": "R Govindan",
      "doi-asserted-by": "publisher",
      "first-page": "1121",
      "issue": "6",
      "journal-title": "Cell.",
      "key": "320_CR8",
      "unstructured": "Govindan R, Ding L, Griffith M, Subramanian J, Dees ND, Kanchi KL, Maher CA, Fulton R, Fulton L, Wallis J, Chen K, Walker J, McDonald S, Bose R, Ornitz D, Xiong D, You M, Dooling DJ, Watson M, Mardis ER, Wilson RK. Genomic landscape of non-small cell lung cancer in smokers and never-smokers. Cell. 2012;150(6):1121–34. https://doi.org/10.1016/j.cell.2012.08.024.",
      "volume": "150",
      "year": "2012"
    },
    {
      "DOI": "10.1126/science.2554494",
      "author": "T Takahashi",
      "doi-asserted-by": "publisher",
      "first-page": "491",
      "issue": "4929",
      "journal-title": "Science.",
      "key": "320_CR9",
      "unstructured": "Takahashi T, Nau MM, Chiba I, Birrer MJ, Rosenberg RK, Vinocour M, Levitt M, Pass H, Gazdar A, Minna J. p53: a frequent target for genetic abnormalities in lung cancer. Science. 1989;246(4929):491–4. https://doi.org/10.1126/science.2554494.",
      "volume": "246",
      "year": "1989"
    },
    {
      "author": "JP Packenham",
      "first-page": "687",
      "issue": "7",
      "journal-title": "Clin Cancer Res",
      "key": "320_CR10",
      "unstructured": "Packenham JP, Taylor JA, White CM, Anna CH, Barrett JC, Devereux TR. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers. Clin Cancer Res. 1995;1(7):687–90.",
      "volume": "1",
      "year": "1995"
    },
    {
      "DOI": "10.1093/jnci/dji055",
      "author": "H Shigematsu",
      "doi-asserted-by": "publisher",
      "first-page": "339",
      "issue": "5",
      "journal-title": "J Natl Cancer Inst",
      "key": "320_CR11",
      "unstructured": "Shigematsu H, Lin L, Takahashi T, Nomura M, Suzuki M, Wistuba II, Fong KM, Lee H, Toyooka S, Shimizu N, Fujisawa T, Feng Z, Roth JA, Herz J, Minna JD, Gazdar AF. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst. 2005;97(5):339–46. https://doi.org/10.1093/jnci/dji055.",
      "volume": "97",
      "year": "2005"
    },
    {
      "author": "S Rodenhuis",
      "first-page": "5738",
      "issue": "20",
      "journal-title": "Cancer Res",
      "key": "320_CR12",
      "unstructured": "Rodenhuis S, Slebos RJ, Boot AJ, Evers SG, Mooi WJ, Wagenaar SS, et al. Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. Cancer Res. 1988;48(20):5738–41.",
      "volume": "48",
      "year": "1988"
    },
    {
      "DOI": "10.1302/2046-3758.91.BJR-2019-0085.R2",
      "author": "JY Choi",
      "doi-asserted-by": "publisher",
      "first-page": "29",
      "issue": "1",
      "journal-title": "Bone Joint Res",
      "key": "320_CR13",
      "unstructured": "Choi JY, Lee YS, Shim DM, Seo SW. Effect of GNAQ alteration on RANKL-induced osteoclastogenesis in human non-small-cell lung cancer. Bone Joint Res. 2020;9(1):29–35. https://doi.org/10.1302/2046-3758.91.BJR-2019-0085.R2.",
      "volume": "9",
      "year": "2020"
    },
    {
      "DOI": "10.1155/2011/583929",
      "author": "A Mogi",
      "doi-asserted-by": "publisher",
      "first-page": "583929",
      "journal-title": "J Biomed Biotechnol",
      "key": "320_CR14",
      "unstructured": "Mogi A, Kuwano H. TP53 mutations in nonsmall cell lung cancer. J Biomed Biotechnol. 2011;2011:583929.",
      "volume": "2011",
      "year": "2011"
    },
    {
      "DOI": "10.1093/mutage/16.6.551",
      "author": "P Hainaut",
      "doi-asserted-by": "publisher",
      "first-page": "551",
      "issue": "6",
      "journal-title": "Mutagenesis.",
      "key": "320_CR15",
      "unstructured": "Hainaut P, Olivier M, Pfeifer GP. TP53 mutation spectrum in lung cancers and mutagenic signature of components of tobacco smoke: lessons from the IARC TP53 mutation database. Mutagenesis. 2001;16(6):551–3; author reply 5-6. https://doi.org/10.1093/mutage/16.6.551.",
      "volume": "16",
      "year": "2001"
    },
    {
      "DOI": "10.3978/j.issn.2218-6751.2015.01.01",
      "author": "CN Prabhakar",
      "doi-asserted-by": "publisher",
      "first-page": "110",
      "issue": "2",
      "journal-title": "Transl Lung Cancer Res",
      "key": "320_CR16",
      "unstructured": "Prabhakar CN. Epidermal growth factor receptor in non-small cell lung cancer. Transl Lung Cancer Res. 2015;4(2):110–8. https://doi.org/10.3978/j.issn.2218-6751.2015.01.01.",
      "volume": "4",
      "year": "2015"
    },
    {
      "DOI": "10.1056/NEJMoa040938",
      "author": "TJ Lynch",
      "doi-asserted-by": "publisher",
      "first-page": "2129",
      "issue": "21",
      "journal-title": "N Engl J Med",
      "key": "320_CR17",
      "unstructured": "Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, Harris PL, Haserlat SM, Supko JG, Haluska FG, Louis DN, Christiani DC, Settleman J, Haber DA. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med. 2004;350(21):2129–39. https://doi.org/10.1056/NEJMoa040938.",
      "volume": "350",
      "year": "2004"
    },
    {
      "DOI": "10.18632/oncotarget.2834",
      "author": "M Scheffler",
      "doi-asserted-by": "publisher",
      "first-page": "1315",
      "issue": "2",
      "journal-title": "Oncotarget.",
      "key": "320_CR18",
      "unstructured": "Scheffler M, Bos M, Gardizi M, Konig K, Michels S, Fassunke J, et al. PIK3CA mutations in non-small cell lung cancer (NSCLC): genetic heterogeneity, prognostic impact and incidence of prior malignancies. Oncotarget. 2015;6(2):1315–26. https://doi.org/10.18632/oncotarget.2834.",
      "volume": "6",
      "year": "2015"
    },
    {
      "DOI": "10.1080/00365513.2016.1183813",
      "author": "X Xu",
      "doi-asserted-by": "publisher",
      "first-page": "386",
      "issue": "5",
      "journal-title": "Scand J Clin Lab Invest",
      "key": "320_CR19",
      "unstructured": "Xu X, Yang Y, Li H, Chen Z, Jiang G, Fei K. Assessment of the clinical application of detecting EGFR, KRAS, PIK3CA and BRAF mutations in patients with non-small cell lung cancer using next-generation sequencing. Scand J Clin Lab Invest. 2016;76(5):386–92. https://doi.org/10.1080/00365513.2016.1183813.",
      "volume": "76",
      "year": "2016"
    },
    {
      "DOI": "10.1158/2159-8290.CD-17-0151",
      "author": "Consortium APG",
      "doi-asserted-by": "publisher",
      "first-page": "818",
      "issue": "8",
      "journal-title": "Cancer Discov",
      "key": "320_CR20",
      "unstructured": "Consortium APG. AACR project GENIE: powering precision medicine through an international consortium. Cancer Discov. 2017;7(8):818–31.",
      "volume": "7",
      "year": "2017"
    },
    {
      "DOI": "10.1038/nature06358",
      "author": "BA Weir",
      "doi-asserted-by": "publisher",
      "first-page": "893",
      "issue": "7171",
      "journal-title": "Nature.",
      "key": "320_CR21",
      "unstructured": "Weir BA, Woo MS, Getz G, Perner S, Ding L, Beroukhim R, Lin WM, Province MA, Kraja A, Johnson LA, Shah K, Sato M, Thomas RK, Barletta JA, Borecki IB, Broderick S, Chang AC, Chiang DY, Chirieac LR, Cho J, Fujii Y, Gazdar AF, Giordano T, Greulich H, Hanna M, Johnson BE, Kris MG, Lash A, Lin L, Lindeman N, Mardis ER, McPherson JD, Minna JD, Morgan MB, Nadel M, Orringer MB, Osborne JR, Ozenberger B, Ramos AH, Robinson J, Roth JA, Rusch V, Sasaki H, Shepherd F, Sougnez C, Spitz MR, Tsao MS, Twomey D, Verhaak RGW, Weinstock GM, Wheeler DA, Winckler W, Yoshizawa A, Yu S, Zakowski MF, Zhang Q, Beer DG, Wistuba II, Watson MA, Garraway LA, Ladanyi M, Travis WD, Pao W, Rubin MA, Gabriel SB, Gibbs RA, Varmus HE, Wilson RK, Lander ES, Meyerson M. Characterizing the cancer genome in lung adenocarcinoma. Nature. 2007;450(7171):893–8. https://doi.org/10.1038/nature06358.",
      "volume": "450",
      "year": "2007"
    },
    {
      "DOI": "10.1038/nature07423",
      "author": "L Ding",
      "doi-asserted-by": "publisher",
      "first-page": "1069",
      "issue": "7216",
      "journal-title": "Nature.",
      "key": "320_CR22",
      "unstructured": "Ding L, Getz G, Wheeler DA, Mardis ER, McLellan MD, Cibulskis K, et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature. 2008;455(7216):1069–75. https://doi.org/10.1038/nature07423.",
      "volume": "455",
      "year": "2008"
    },
    {
      "DOI": "10.1158/1541-7786.MCR-08-0532",
      "author": "B Modrek",
      "doi-asserted-by": "publisher",
      "first-page": "1244",
      "issue": "8",
      "journal-title": "Mol Cancer Res",
      "key": "320_CR23",
      "unstructured": "Modrek B, Ge L, Pandita A, Lin E, Mohan S, Yue P, Guerrero S, Lin WM, Pham T, Modrusan Z, Seshagiri S, Stern HM, Waring P, Garraway LA, Chant J, Stokoe D, Cavet G. Oncogenic activating mutations are associated with local copy gain. Mol Cancer Res. 2009;7(8):1244–52. https://doi.org/10.1158/1541-7786.MCR-08-0532.",
      "volume": "7",
      "year": "2009"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-10-2185",
      "author": "P Broet",
      "doi-asserted-by": "publisher",
      "first-page": "3542",
      "issue": "11",
      "journal-title": "Clin Cancer Res",
      "key": "320_CR24",
      "unstructured": "Broet P, Dalmasso C, Tan EH, Alifano M, Zhang S, Wu J, et al. Genomic profiles specific to patient ethnicity in lung adenocarcinoma. Clin Cancer Res. 2011;17(11):3542–50. https://doi.org/10.1158/1078-0432.CCR-10-2185.",
      "volume": "17",
      "year": "2011"
    },
    {
      "DOI": "10.1038/nm.2658",
      "author": "K Takeuchi",
      "doi-asserted-by": "publisher",
      "first-page": "378",
      "issue": "3",
      "journal-title": "Nat Med",
      "key": "320_CR25",
      "unstructured": "Takeuchi K, Soda M, Togashi Y, Suzuki R, Sakata S, Hatano S, Asaka R, Hamanaka W, Ninomiya H, Uehara H, Lim Choi Y, Satoh Y, Okumura S, Nakagawa K, Mano H, Ishikawa Y. RET, ROS1 and ALK fusions in lung cancer. Nat Med. 2012;18(3):378–81. https://doi.org/10.1038/nm.2658.",
      "volume": "18",
      "year": "2012"
    },
    {
      "DOI": "10.1517/14728222.9.3.533",
      "author": "NW Choong",
      "doi-asserted-by": "publisher",
      "first-page": "533",
      "issue": "3",
      "journal-title": "Expert Opin Ther Targets",
      "key": "320_CR26",
      "unstructured": "Choong NW, Ma PC, Salgia R. Therapeutic targeting of receptor tyrosine kinases in lung cancer. Expert Opin Ther Targets. 2005;9(3):533–59. https://doi.org/10.1517/14728222.9.3.533.",
      "volume": "9",
      "year": "2005"
    },
    {
      "DOI": "10.3390/cells7080107",
      "doi-asserted-by": "crossref",
      "key": "320_CR27",
      "unstructured": "Hasanovic A, Mus-Veteau I. Targeting the multidrug transporter Ptch1 potentiates chemotherapy efficiency. Cells. 2018;7(8)."
    },
    {
      "DOI": "10.1038/nmeth.1628",
      "author": "J Wang",
      "doi-asserted-by": "publisher",
      "first-page": "652",
      "issue": "8",
      "journal-title": "Nat Methods",
      "key": "320_CR28",
      "unstructured": "Wang J, Mullighan CG, Easton J, Roberts S, Heatley SL, Ma J, Rusch MC, Chen K, Harris CC, Ding L, Holmfeldt L, Payne-Turner D, Fan X, Wei L, Zhao D, Obenauer JC, Naeve C, Mardis ER, Wilson RK, Downing JR, Zhang J. CREST maps somatic structural variation in cancer genomes with base-pair resolution. Nat Methods. 2011;8(8):652–4. https://doi.org/10.1038/nmeth.1628.",
      "volume": "8",
      "year": "2011"
    },
    {
      "DOI": "10.1093/bioinformatics/btv710",
      "author": "X Chen",
      "doi-asserted-by": "publisher",
      "first-page": "1220",
      "issue": "8",
      "journal-title": "Bioinformatics.",
      "key": "320_CR29",
      "unstructured": "Chen X, Schulz-Trieglaff O, Shaw R, Barnes B, Schlesinger F, Kallberg M, et al. Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications. Bioinformatics. 2016;32(8):1220–2. https://doi.org/10.1093/bioinformatics/btv710.",
      "volume": "32",
      "year": "2016"
    },
    {
      "DOI": "10.1038/nbt.2514",
      "author": "K Cibulskis",
      "doi-asserted-by": "publisher",
      "first-page": "213",
      "issue": "3",
      "journal-title": "Nat Biotechnol",
      "key": "320_CR30",
      "unstructured": "Cibulskis K, Lawrence MS, Carter SL, Sivachenko A, Jaffe D, Sougnez C, Gabriel S, Meyerson M, Lander ES, Getz G. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013;31(3):213–9. https://doi.org/10.1038/nbt.2514.",
      "volume": "31",
      "year": "2013"
    },
    {
      "DOI": "10.1093/bioinformatics/btp394",
      "author": "K Ye",
      "doi-asserted-by": "publisher",
      "first-page": "2865",
      "issue": "21",
      "journal-title": "Bioinformatics.",
      "key": "320_CR31",
      "unstructured": "Ye K, Schulz MH, Long Q, Apweiler R, Ning Z. Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads. Bioinformatics. 2009;25(21):2865–71. https://doi.org/10.1093/bioinformatics/btp394.",
      "volume": "25",
      "year": "2009"
    }
  ],
  "reference-count": 31,
  "references-count": 31,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-021-00320-9"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "Targeted exome sequencing identifies mutational landscape in a cohort of 1500 Chinese patients with non-small cell lung carcinoma (NSCLC)"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "15"
}